Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ultrasound-guided Radiofrequency Ablation Versus Radioactive Iodine as Treatment for Hyperthyroidism Caused by Solitary Autonomous Thyroid Nodules

NCT05142904 is registered in ClinicalTrials.gov with Rijnstate Hospital as lead sponsor.

NCT NCT05142904
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05142904 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ultrasound-guided Radiofrequency Ablation Versus Radioactive Iodine as Treatment for Hyperthyroidism Caused by Solitary Autonomous Thyroid Nodules
Lead sponsor
Rijnstate Hospital
Phase
Phase 3
Overall status
Terminated
Start date
November 17, 2021
Completion date
November 1, 2024
Enrollment
40 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

autonomous thyroid function, iodine adverse reaction, iodine hyperthyroidism, radiofrequency ablation, thyroid nodule, toxic or with hyperthyroidism, thyroid nodule; hyperthyroidism